This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Merck & Co., Inc.
Drug Names(s): V-114, Pneumococcal Conjugate Vaccine, 15-valent Pneumococcal Conjugate Vaccine, PCV15
Description: V114 is a pneumococcal conjugate vaccine. Merck is testing both an aluminum-adjuvanted and non-adjuvanted version of the vaccine.
Additional information available to subscribers only: